Pseudomonas Aeruginosa Can Diversify After Host Cell Invasion to Establish Multiple Intracellular Niches
Overview
Authors
Affiliations
Within epithelial cells, Pseudomonas aeruginosa depends on its type III secretion system (T3SS) to escape vacuoles and replicate rapidly in the cytosol. Previously, it was assumed that intracellular subpopulations remaining T3SS-negative (and therefore in vacuoles) were destined for degradation in lysosomes, supported by data showing vacuole acidification. Here, we report in both corneal and bronchial human epithelial cells that vacuole-associated bacteria can persist, sometimes in the same cells as cytosolic bacteria. Using a combination of phase-contrast, confocal, and correlative light-electron microscopy (CLEM), we also found they can demonstrate biofilm-associated markers: and cyclic-di-GMP (c-di-GMP). Vacuolar-associated bacteria, but not their cytosolic counterparts, tolerated the cell-permeable antibiotic ofloxacin. Surprisingly, use of mutants showed that both persistence in vacuoles and ofloxacin tolerance were independent of the biofilm-associated protein CdrA or exopolysaccharides (Psl, Pel, alginate). A T3SS mutant (Δ) unable to escape vacuoles phenocopied vacuole-associated subpopulations in wild-type PAO1-infected cells, with results revealing that epithelial cell death depended upon bacterial viability. Intravital confocal imaging of infected mouse corneas confirmed that P. aeruginosa formed similar intracellular subpopulations within epithelial cells . Together, these results show that P. aeruginosa differs from other pathogens by diversifying intracellularly into vacuolar and cytosolic subpopulations that both contribute to pathogenesis. Their different gene expression and behavior (e.g., rapid replication versus slow replication/persistence) suggest cooperation favoring both short- and long-term interests and another potential pathway to treatment failure. How this intracellular diversification relates to previously described "acute versus chronic" virulence gene-expression phenotypes of P. aeruginosa remains to be determined. Pseudomonas aeruginosa can cause sight- and life-threatening opportunistic infections, and its evolving antibiotic resistance is a growing concern. Most P. aeruginosa strains can invade host cells, presenting a challenge to therapies that do not penetrate host cell membranes. Previously, we showed that the P. aeruginosa type III secretion system (T3SS) plays a pivotal role in survival within epithelial cells, allowing escape from vacuoles, rapid replication in the cytoplasm, and suppression of host cell death. Here, we report the discovery of a novel T3SS-negative subpopulation of intracellular P. aeruginosa within epithelial cells that persist in vacuoles rather than the cytoplasm and that tolerate a cell-permeable antibiotic (ofloxacin) that is able to kill cytosolic bacteria. Classical biofilm-associated markers, although demonstrated by this subpopulation, are not required for vacuolar persistence or antibiotic tolerance. These findings advance our understanding of how P. aeruginosa hijacks host cells, showing that it diversifies into multiple populations with T3SS-negative members enabling persistence while rapid replication is accomplished by more vulnerable T3SS-positive siblings. Intracellular P. aeruginosa persisting and tolerating antibiotics independently of the T3SS or biofilm-associated factors could present additional challenges to development of more effective therapeutics.
Cross-membrane cooperation among bacteria can facilitate intracellular pathogenesis.
Schator D, Kumar N, Chong S, Jung T, Jedel E, Smith B bioRxiv. 2025; .
PMID: 39975129 PMC: 11839010. DOI: 10.1101/2025.02.09.637186.
The T3SS can contribute to traversal of an epithelial multilayer independently of the T3SS needle.
Jedel E, Schator D, Kumar N, Sullivan A, Rietsch A, Evans D bioRxiv. 2025; .
PMID: 39975055 PMC: 11838347. DOI: 10.1101/2025.01.28.635263.
Pont S, Nilly F, Berry L, Bonhoure A, Alford M, Louis M PLoS Pathog. 2025; 21(2):e1012922.
PMID: 39946497 PMC: 11825101. DOI: 10.1371/journal.ppat.1012922.
Human airway epithelium controls infection via inducible nitric oxide synthase.
Grubwieser P, Bock N, Soto E, Hilbe R, Moser P, Seifert M Front Immunol. 2024; 15:1508727.
PMID: 39691712 PMC: 11649544. DOI: 10.3389/fimmu.2024.1508727.
Substrate identification of putative NCS1 and NCS2 nucleobase transporters in .
Kennelly C, Prindle A mBio. 2024; 15(12):e0243424.
PMID: 39475230 PMC: 11633122. DOI: 10.1128/mbio.02434-24.